Skip to search formSkip to main contentSkip to account menu

maropitant citrate

Known as: (2S,3S)-N-(5-(1,1-Dimethylethyl)-2-methoxybenzyl)-2-(diphenylmethyl)-1-azabicyclo(2.2.2)octan-3-amine 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate, 2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate 
A neurokinin receptor antagonist with antiemetic activity. This agent is approved for veterinary use only.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Retrospective analysis of post‐operative vomiting (POV) in non‐human primates at our institution was 11%. Based on this… 
2016
2016
O citrato de maropitant e um antiemetico veterinario antagonista do receptor NK-1. Objetivou-se investigar alteracoes… 
2013
2013
The pharmacokinetics of maropitant were evaluated in beagle dogs dosed orally with Cerenia® tablets (Pfizer Animal Health) once… 
2013
2013
PURPOSE To describe anterior segment fluorescein angiography (ASFA) of the normal feline eye using a digital single-lens reflex… 
2011
2011
Murine ulcerative dermatitis (UD) is a common progressive condition of mice with a C57BL/6 background. Typically, mice present… 
2010
2010
An 8-year-old, spayed-female Golden Retriever was evaluated at the Cornell University Hospital for Animals for complaints of…